Loading...
DaVita's Q2 2020 results showed a focus on patient and staff safety amidst the COVID-19 pandemic. The company reported consolidated revenues of $2.880 billion, operating income of $410 million, and diluted earnings per share from continuing operations of $1.62.
Consolidated revenues reached $2.880 billion.
Operating income was $410 million, representing a 14.2% operating margin.
Diluted earnings per share from continuing operations were $1.62.
The company issued $1.750 billion of 4.625% senior notes to redeem existing 5.125% senior notes.
DaVita provided its 2020 guidance with revenue between $11.5 billion and $11.7 billion.
Visualization of income flow from segment revenue to net income